Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy
Clinical trial NCT00722072 · TERMINATED
Trial details
- NCT number
- NCT00722072
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.